|
CY2018004I2
(en)
|
|
SUBSTITUTED OXAZOLIDINONE COMBINATION THERAPY
|
|
DK3424932T3
(en)
|
|
Bronophthalides for therapeutic use
|
|
DK2041139T3
(en)
|
|
Pharmaceutical compounds
|
|
ATE443753T1
(en)
|
|
NUANCEMENT AGENTS
|
|
DK1986650T3
(en)
|
|
MANIPULATION-SAFE DOSAGE FORMS
|
|
DK2035369T3
(en)
|
|
THERAPEUTIC
|
|
DK2144905T3
(en)
|
|
Therapeutic agents
|
|
FR2896407B3
(en)
|
|
walker
|
|
BRPI0916931A2
(en)
|
|
therapeutic agents
|
|
FI20065069A
(en)
|
|
Connection mechanism
|
|
DK2073795T3
(en)
|
|
Abuse-safe drug formulation
|
|
DE602007012130D1
(en)
|
|
MODIFIED FLAVIN-ADENINE-DINUCLEOTIDE-DEPENDENT GLUCOSE-DEHYDROGENASE
|
|
ATE524477T1
(en)
|
|
AZIRIDINYLEPOTHILONE COMPOUNDS
|
|
AT504580A3
(en)
|
|
SCAN-DEVICE
|
|
DK2094292T3
(en)
|
|
SALPETEROXIDE-BLOCKED CROSS-TETRAMERIC HEMOGLOBIN
|
|
DK2178568T3
(en)
|
|
CONTRAST AGENTS
|
|
ATE546437T1
(en)
|
|
AMINOMETHYL-4-IMIDAZOLE
|
|
DE502007000218D1
(en)
|
|
nsetzungen
|
|
DE502007002453D1
(en)
|
|
Kunstoffverdichtergehäuse
|
|
DE602006020744D1
(en)
|
|
SYRINGE
|
|
DE502006006067D1
(en)
|
|
NG
|
|
ATE534010T1
(en)
|
|
SCOPE
|
|
DE502007001629D1
(en)
|
|
RFAHREN
|
|
DE502007000361D1
(en)
|
|
Stanznieteinheit
|
|
BRPI0820410A2
(en)
|
|
Therapeutic Substituted Lactans
|